Hexavalent Vaccines in India: Current Status

被引：7

作者：

Chitkara, Amar Jeet ^{[1
]}

Parikh, Raunak ^{[2
]}

Mihalyi, Attila ^{[3
]}

Kolhapure, Shafi ^{[2
]}

机构：

[1] Max Superspecial Hosp, Dept Pediat, Delhi, India

[2] Glaxo Smith Kline Biol SA, Mumbai, Maharashtra, India

[3] Glaxo Smith Kline Biol SA, Wavre, Belgium

来源：

INDIAN PEDIATRICS | 2019年 / 56卷 / 11期

关键词：

Combination vaccines; Acellular Vaccine; Immunization; Pertussis; PNEUMOCOCCAL CONJUGATE VACCINE; ACELLULAR PERTUSSIS-VACCINE; 3-DOSE PRIMARY VACCINATION; DTPA-HBV-IPV/HIB; ROUTINE INFANT; B VACCINE; COMBINATION VACCINES; IMMUNOGENICITY; SAFETY; IMMUNIZATION;

D O I：

10.1007/s13312-019-1651-y

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Hexavalent vaccines containing diphtheria, tetanus, pertussis, Haemophilus influenzae type b, poliomyelitis, and hepatitis B virus antigens have the potential to be used for the primary series in India (6, 10, 14 weeks of age) and the toddler booster dose. Three hexavalent vaccines are available in India: DTwP-Hib/HepB-IPV (wP-hexa), DTaP-IPV-HB-PRPT(2aP-hexa), and DTaP-HBV-IPV/Hib (3aP-hexa). In the three published phase-3 Indian studies, pertussis 'vaccine response' rates 1 month after a 6-10-14-week primary series were 68.4-75.7% for wP-hexa, 93.8-99.3% for 2aP-hexa, and 97.0-100% for 3aP-hexa; seroprotection rates for the other five antigens were 88.2-100%, 49.6-100%, and 98.6-100%, respectively. Studies outside India show: good immunogenicity/safety after boosting dosing; immune persistence to age 4.5 years (2aP-hexa), 7-9 years (3aP-hexa) (all antigens), and 9-10 and 14-15 years, respectively (hepatitis B); and successful co-administration with other vaccines. Hexavalent vaccines could reduce the number of injections, simplify vaccination schedules, and improve compliance.

引用

页码：939 / 950

页数：12

共 65 条

[51] Combination Vaccines [J].

Skibinski, David A. G. ;

Baudner, Barbara C. ;

Singh, Manmohan ;

O'Hagan, Derek T. .

JOURNAL OF GLOBAL INFECTIOUS DISEASES, 2011, 3 (01) :63-72

[52] Immunogenicity and reactogenicity of a three-dose primary vaccination course with a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type b vaccine coadministered with a meningococcal C conjugate vaccine [J].

Tejedor, JC ;

Omeñaca, F ;

García-Sicilia, D ;

Verdaguer, J ;

Van Esso, D ;

Esporrín, C ;

Molina, V ;

Muro, M ;

Marés, J ;

Enrubia, M ;

Moraga, F ;

García-Corbeira, P ;

Dobbelaere, K ;

Schuerman, L .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (12) :1109-1115

[53] Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine [J].

Tejedor, Juan C. ;

Moro, Manuel ;

Ruiz-Contreras, Jesus ;

Castro, Javier ;

Gomez-Campdera, Jose A. ;

Navarro, Maria Luisa ;

Merino, Jose Manuel ;

Martin-Ancel, Ana ;

Roca, Joan ;

Garcia-del-Rio, Manuel ;

Jurado, Antonio ;

Diez-Delgado, Francisco Javier ;

Omenaca, Felix ;

Garcia-Sicilia, Jose ;

Boceta, Reyes ;

Garcia-Corbeira, Pilar ;

Jacquet, Jeanne-Marie ;

Collard, Alix ;

Schuerman, Lode .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2006, 25 (08) :713-720

[54] Pertussis vaccines: Position paper of Indian Academy of Pediatrics (IAP) [J].

Vashishtha, Vipin M. ;

Bansal, C. P. ;

Gupta, Sailesh G. .

INDIAN PEDIATRICS, 2013, 50 (11) :1001-1009

[55] Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials [J].

Vesikari, Timo ;

Esposito, Susanna ;

Prymula, Roman ;

Ypma, Ellen ;

Kohl, Igor ;

Toneatto, Daniela ;

Dull, Peter ;

Kimura, Alan .

LANCET, 2013, 381 (9869) :825-835

[56] Immunogenicity and safety of the human rotavirus vaccine Rotarix™ co-administered with routine infant vaccines following the vaccination schedules in Europe [J].

Vesikari, Timo ;

Karvonen, Aino ;

Prymula, Roman ;

Schuster, Volker ;

Tejedor, Juan C. ;

Thollot, Franck ;

Garcia-Corbeira, Pilar ;

Damaso, Silvia ;

Han, Htay-Htay ;

Bouckenooghe, Alain .

VACCINE, 2010, 28 (32) :5272-5279

[57]

WHO SAGE pertussis working group, BACKGR PAP

[58]

World Health Organization, INTR IN POL VACC IPV

[59]

World Health Organization, 2015, REPL TRIV OPV BIV OP

[60]

World Health Organization, 2017, WHO UNICEF EST NAT I

← 1 2 3 4 5 6 7 →